Oncopeptides sets Oct. 12 webcast after positive interim OP-701 data
Oncopeptides AB (publ) plans an Oct 12, 08:00 CET webcast after announcing positive interim OP-701 data in glioblastoma patients, saying its PDC platform penetrated the human blood-brain barrier.